About
Drug delivery technology; small molecule for cancer
Areas of Focus
Categories
Small Molecule PharmaceuticalDrug Delivery & Formulation
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
114
By Phase
PHASE1: 1PHASE2: 2PHASE1/PHASE2: 1
By Status
COMPLETED: 3TERMINATED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
Today
Hover over trial bars to see details
Recent Trials
NCT04810208Lead Sponsor
Intratumoural Injection of a Novel NanoZolid®-Docetaxel Depot Formulation in Patients With Advanced Solid Tumours
PHASE1Terminated
6 participants
Started: Feb 28, 2019 · Completed: Oct 7, 2021
NCT03348527Lead Sponsor
A Study to Evaluate the Safety, Tolerability and Efficacy of a Liproca® Depot Injection in Patients With Prostate Cancer
PHASE2Completed
61 participants
Started: May 12, 2017 · Completed: Nov 30, 2020
NCT02341404Lead Sponsor
A Study of 2-hydroxyflutamide (Liproca Depot), Injected Into the Prostate in Patients With Localized Prostate Cancer
PHASE2Completed
23 participants
Started: May 31, 2012 · Completed: May 31, 2015
NCT00913263Lead Sponsor
An Efficacy and Safety Study With Licroca Depot, a Controlled Release Product, Injected Into the Prostate
PHASE1/PHASE2Completed
24 participants
Started: Jun 30, 2009 · Completed: Jul 31, 2011
Locations (1)
Headquarters
Uppsala, Sweden
Map
Loading map...